AU2001234837A1 - Azapeptides useful in the treatment of hepatitis c - Google Patents

Azapeptides useful in the treatment of hepatitis c

Info

Publication number
AU2001234837A1
AU2001234837A1 AU2001234837A AU3483701A AU2001234837A1 AU 2001234837 A1 AU2001234837 A1 AU 2001234837A1 AU 2001234837 A AU2001234837 A AU 2001234837A AU 3483701 A AU3483701 A AU 3483701A AU 2001234837 A1 AU2001234837 A1 AU 2001234837A1
Authority
AU
Australia
Prior art keywords
azapeptides
hepatitis
useful
treatment
azapeptides useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234837A
Inventor
Rumin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001234837A1 publication Critical patent/AU2001234837A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001234837A 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c Abandoned AU2001234837A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18101700P 2000-02-08 2000-02-08
US60181017 2000-02-08
PCT/US2001/003768 WO2001058929A1 (en) 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
AU2001234837A1 true AU2001234837A1 (en) 2001-08-20

Family

ID=22662539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234837A Abandoned AU2001234837A1 (en) 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c

Country Status (3)

Country Link
US (1) US6624290B2 (en)
AU (1) AU2001234837A1 (en)
WO (1) WO2001058929A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119072B2 (en) 2002-01-30 2006-10-10 Boehringer Ingelheim (Canada) Ltd. Macrocyclic peptides active against the hepatitis C virus
US6642204B2 (en) 2002-02-01 2003-11-04 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US7091184B2 (en) 2002-02-01 2006-08-15 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US20050075279A1 (en) 2002-10-25 2005-04-07 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
PT1654261E (en) 2003-05-21 2008-01-18 Boehringer Ingelheim Int Hepatitis c inhibitor compounds
TW201127828A (en) 2003-09-05 2011-08-16 Vertex Pharma Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
DE602004031645D1 (en) 2003-09-22 2011-04-14 Boehringer Ingelheim Pharma MACROCYCLIC PEPTIDES WITH EFFECT AGAINST HEPATITIS C VIRUS
CA2549851C (en) 2004-01-21 2012-09-11 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis c virus
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
PT1719773E (en) 2004-02-24 2009-06-03 Japan Tobacco Inc Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
EP1771454B1 (en) 2004-07-20 2011-06-15 Boehringer Ingelheim International GmbH Hepatitis c inhibitor peptide analogs
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (en) 2005-08-26 2007-08-22 Vertex Pharma INHIBITING COMPOUNDS OF THE ACTIVITY OF SERINA PROTEASA NS3-NS4A OF HEPATITIS C VIRUS
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
EP1886685A1 (en) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
US20100104534A1 (en) * 2007-03-23 2010-04-29 Srikanth Venkatraman Hydrazido-peptides as inhibitors of hcv ns3-protease
EP3025727A1 (en) 2008-10-02 2016-06-01 The J. David Gladstone Institutes Methods of treating liver disease
EP2408449A4 (en) 2009-03-18 2012-08-08 Univ Leland Stanford Junior Methods and compositions of treating a flaviviridae family viral infection
WO2012107589A1 (en) 2011-02-11 2012-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
MX349036B (en) 2011-12-06 2017-07-07 Univ Leland Stanford Junior Methods and compositions for treating viral diseases.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684674B1 (en) 1991-12-10 1994-01-28 Thevac Sarl AZAPEPTIDES AND THEIR PREPARATION PROCESS.
DE69519182T2 (en) 1994-03-17 2001-05-17 Fujirebio Kk Azapeptide derivatives

Also Published As

Publication number Publication date
US20020103135A1 (en) 2002-08-01
WO2001058929A1 (en) 2001-08-16
US6624290B2 (en) 2003-09-23

Similar Documents

Publication Publication Date Title
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2002223827A1 (en) Well treatment
AU2001282449A1 (en) Applications of the biofeedback technique
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001243394A1 (en) Compounds and methods
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001260834A1 (en) The treatment of herpes
AU2002231206A1 (en) Treatment of depression
AU2002213429A1 (en) Antiviral methods and compounds
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001236929A1 (en) Surface treatment
AU2001278951A1 (en) Compounds and methods
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
GB0014580D0 (en) Appatarus and process
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU5565401A (en) Materials and methods for the treatment of depression